Glycosaminoglycan signatures in body fluids of mucopolysaccharidosis type II mouse model under long-term enzyme replacement therapy.

MLA

Maccari, Francesca, et al. “Glycosaminoglycan Signatures in Body Fluids of Mucopolysaccharidosis Type II Mouse Model under Long-Term Enzyme Replacement Therapy.” Journal of Molecular Medicine (Berlin, Germany), vol. 100, no. 8, Aug. 2022, pp. 1169–79. EBSCOhost, https://doi.org/10.1007/s00109-022-02221-3.

APA

Maccari, F., Rigon, L., Mantovani, V., Galeotti, F., Salvalaio, M., D’Avanzo, F., Zanetti, A., Capitani, F., Gabrielli, O., Tomanin, R., & Volpi, N. (2022). Glycosaminoglycan signatures in body fluids of mucopolysaccharidosis type II mouse model under long-term enzyme replacement therapy. Journal of Molecular Medicine (Berlin, Germany), 100(8), 1169–1179. https://doi.org/10.1007/s00109-022-02221-3

Chicago

Maccari, Francesca, Laura Rigon, Veronica Mantovani, Fabio Galeotti, Marika Salvalaio, Francesca D’Avanzo, Alessandra Zanetti, et al. 2022. “Glycosaminoglycan Signatures in Body Fluids of Mucopolysaccharidosis Type II Mouse Model under Long-Term Enzyme Replacement Therapy.” Journal of Molecular Medicine (Berlin, Germany) 100 (8): 1169–79. doi:10.1007/s00109-022-02221-3.